Saudi Bronchoscopy Survey Found Midazolam Use Alongside Gaps in Reversal-Agent Availability

Written by

in

A practice survey described commonly reported bronchoscopy sedatives and uneven access to antagonist medicines. The responses did not measure actual patient complication rates.

What clinicians reported

Eighty-two of 456 invited practitioners completed the survey, an eighteen-percent response rate. Midazolam and fentanyl were commonly reported, with differences among specialties.

Reversal agents were available to all responding thoracic surgeons but were unavailable to some responding intensivists and pulmonologists. This was a reported preparedness measure rather than a count of failed rescues.

Interpret the survey denominator

A low response rate permits nonresponse bias, and reported practice may differ from observed practice. Training, service type, and case mix can also influence medication choices.

The study does not establish that a particular patient suffered harm or that every respondent followed the same sedation protocol. In reviewing a bronchoscopy, examine actual monitoring, drug administration, rescue resources, and interventions. Population practice reports can identify questions to investigate, but cannot substitute for the contemporaneous clinical record.

Source paper

Original analysis of the supplied journal article, identified as PMC6468201.

Related research

Comments

Leave a Reply

Your email address will not be published. Required fields are marked *